News

AddToAny

Google+ Facebook Twitter Twitter

Diagnosing prostate cancer

Genetic alterations in low-risk prostate cancer diagnosed by needle biopsy can identify men that harbour higher-risk cancer in their prostate glands, according to new research.

The study is the first to report that genetic alterations associated with intermediate- and high-risk prostate cancer also may be present in some low-risk cases.

The study found the needle biopsy procedure may miss higher-risk cancer that increases the risk of disease progression. The researchers said that men diagnosed with low-risk cancer may benefit from additional testing for these chromosomal alterations.

George Vasmatzis, lead researcher, said: “We have discovered molecular markers that can help guide men in their decisions about the course of their prostate cancer care.

“We found that the presence of genetic alterations in low-risk cancer can help men decide whether treatment or active surveillance is right for them.”

Picture credit | iStock

Related Articles

Robotic hand with handgun aiming in wrong direction. Fatal AI error - Image credit - Shutterstock-2309476357

Tissue contamination distracts AI

In a new study, scientists trained three AI models to scan microscope slides of placenta tissue to detect blood vessel damage, estimate gestational age and classify macroscopic lesions.

Digital pathology cleared for use-history digital pathology-CREDIT-university of warwick

Digital pathology cleared for use

New research has led to the UK government approving the use of digital pathology to help speed up analysis of cancer screening samples.

Breast cancer 3D tomography-CREDIT-Science-Photo-Library-c0303374

Two decades of hHER2 testing

This year marks the 20th anniversary of Her2 breast cancer testing at the Royal Cornwall Hospital. Senior Biomedical Scientist Mary Jones looks back over the past two decades.

A molecular biologist working with a microscope in a modern scientific Laboratory, we see a computer screen in the foreground- CREDIT - istock-1390303303

Precision pathology for cancer with new ai tool

A new AI tool interprets medical images with unprecedented clarity, according to the results of a new study.

Top